Matthew Moyle
2016
In 2016, Matthew Moyle earned a total compensation of $877.9K as Chief Scientific Officer at ANAPTYSBIO.
Compensation breakdown
| Bonus | $44,405 |
|---|---|
| Option Awards | $614,546 |
| Salary | $181,250 |
| Other | $37,726 |
| Total | $877,927 |
Moyle received $614.5K in option awards, accounting for 70% of the total pay in 2016.
Moyle also received $44.4K in bonus, $181.3K in salary and $37.7K in other compensation.
Rankings
In 2016, Matthew Moyle's compensation ranked 8,858th out of 14,075 executives tracked by ExecPay. In other words, Moyle earned more than 37.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,858 out of 14,075 | 37th |
Division Manufacturing | 3,428 out of 5,489 | 38th |
Major group Chemicals And Allied Products | 1,162 out of 1,895 | 39th |
Industry group Drugs | 915 out of 1,538 | 41st |
Industry Pharmaceutical Preparations | 730 out of 1,176 | 38th |
Source: SEC filing on April 26, 2018.
Moyle's colleagues
We found two more compensation records of executives who worked with Matthew Moyle at ANAPTYSBIO in 2016.